Related references
Note: Only part of the references are listed.Matrix Metalloproteinases in COPD and atherosclerosis with emphasis on the effects of smoking
M. Kraen et al.
PLOS ONE (2019)
PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma
Honghai Ma et al.
SCIENTIFIC REPORTS (2019)
Extracellular Matrix Component Remodeling in Respiratory Diseases: What Has Been Found in Clinical and Experimental Studies?
Juliana T. Ito et al.
CELLS (2019)
Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer
Weiwei Gong et al.
BMC CANCER (2019)
Uncovering the clinical impact of kallikrein-related peptidase 5 (KLK5) mRNA expression in the colorectal adenoma-carcinoma sequence
Georgia Papachristopoulou et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Physiological and pathological roles of kallikrein-related peptidases in the epidermis
Mari Kishibe
JOURNAL OF DERMATOLOGICAL SCIENCE (2019)
Cigarette Smoke Induced Lung Barrier Dysfunction, EMT, and Tissue Remodeling: A Possible Link between COPD and Lung Cancer
Wei Hou et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Membrane-Anchored Serine Proteases and Protease-Activated Receptor-2-Mediated Signaling: Co-Conspirators in Cancer Progression
Nisha R. Pawar et al.
CANCER RESEARCH (2019)
Airway wall thickening on CT: Relation to smoking status and severity of COPD
Jean-Paul Charbonnier et al.
RESPIRATORY MEDICINE (2019)
The pathology of small airways disease in COPD: historical aspects and future directions
Andrew Higham et al.
RESPIRATORY RESEARCH (2019)
Inhibitors of kallikrein-related peptidases: An overview
Nicolas Masurier et al.
MEDICINAL RESEARCH REVIEWS (2018)
Kallikrein-related peptidase 7 overexpression in melanoma cells modulates cell adhesion leading to a malignant phenotype
Meriem Haddada et al.
BIOLOGICAL CHEMISTRY (2018)
Kallikrein-related peptidases in lung diseases
Woodys Lenga Ma Bonda et al.
BIOLOGICAL CHEMISTRY (2018)
Human lung epithelial cell cultures for analysis of inhaled toxicants: Lessons learned and future directions
Pieter S. Hiemstra et al.
TOXICOLOGY IN VITRO (2018)
Human kallikrein-related peptidase 12 stimulates endothelial cell migration by remodeling the fibronectin matrix
T. Kryza et al.
SCIENTIFIC REPORTS (2018)
Kallikrein-Related Peptidase 5 Contributes to H3N2 Influenza Virus Infection in Human Lungs
Melia Magnen et al.
JOURNAL OF VIROLOGY (2017)
Matrix Metalloproteinases and Their Inhibitors in Chronic Obstructive Pulmonary Disease
Zdenka Navratilova et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2016)
SCN4B acts as a metastasis-suppressor gene preventing hyperactivation of cell migration in breast cancer
Emeline Bon et al.
Nature Communications (2016)
Neutrophil elastase cleaves epithelial cadherin in acutely injured lung epithelium
Rachel Boxio et al.
RESPIRATORY RESEARCH (2016)
Expression and bioregulation of the kallikrein-related peptidases family in the human neutrophil
Alejandro J. Lizama et al.
INNATE IMMUNITY (2015)
Bronchial epithelial cells: The key effector cells in the pathogenesis of chronic obstructive pulmonary disease?
Wei Gao et al.
RESPIROLOGY (2015)
Fibroblast-epithelial cell interactions drive epithelial-mesenchymal transition differently in cells from normal and COPD patients
Michiyoshi Nishioka et al.
RESPIRATORY RESEARCH (2015)
Human tissue kallikreins 3 and 5 can act as plasminogen activator releasing active plasmin
Lucas R. de Souza et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Cigarette smoke disrupts the integrity of airway adherens junctions through the aberrant interaction of p120-catenin with the cytoplasmic tail of MUC1
Lili Zhang et al.
JOURNAL OF PATHOLOGY (2013)
Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer
Marion Lavergne et al.
FEBS OPEN BIO (2013)
Characterization of SPINK9, a KLK5-specific inhibitor expressed in palmo-plantar epidermis
Kristoffer Brannstrom et al.
BIOLOGICAL CHEMISTRY (2012)
Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance
Daniela Loessner et al.
GYNECOLOGIC ONCOLOGY (2012)
The effect of human antibacterial peptide LL-37 in the pathogenesis of chronic obstructive pulmonary disease
Yuan-Yuan Jiang et al.
RESPIRATORY MEDICINE (2012)
Kallikrein-related Peptidase 12 Hydrolyzes Matricellular Proteins of the CCN Family and Modifies Interactions of CCN1 and CCN5 with Growth Factors
Audrey Guillon-Munos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions
Guillaume Gaud et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
The Epithelial Cell and Lung Cancer: The Link between Chronic Obstructive Pulmonary Disease and Lung Cancer
Claire Rooney et al.
RESPIRATION (2011)
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
Peter Goettig et al.
BIOCHIMIE (2010)
Potential role of multiple members of the kallikrein-related peptidase family of serine proteases in activating latent TGF beta 1 in semen
Nashmil Emami et al.
BIOLOGICAL CHEMISTRY (2010)
Isolation of SPINK6 in Human Skin SELECTIVE INHIBITOR OF KALLIKREIN-RELATED PEPTIDASES
Ulf Meyer-Hoffert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion
Sophie Iochmann et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome
Anais Briot et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Identification of Lympho-Epithelial Kazal-Type Inhibitor 2 in Human Skin as a Kallikrein-Related Peptidase 5-Specific Protease Inhibitor
Ulf Meyer-Hoffert et al.
PLOS ONE (2009)
Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea
Kenshi Yamasaki et al.
NATURE MEDICINE (2007)
Proteinase-activated receptors, targets for kallikrein signaling
Katerina Oikonomopoulou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin
Kenshi Yamasaki et al.
FASEB JOURNAL (2006)
Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome
Pascal Descargues et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells
Panagiotis Prezas et al.
BIOLOGICAL CHEMISTRY (2006)
Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression
IP Michael et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structure, function and biology of tissue factor pathway inhibitor-2
HS Chand et al.
THROMBOSIS AND HAEMOSTASIS (2005)
KLK5 and KLK7, two members of the human tissue, kallikrein family, are differentially expressed in lung cancer
C Planque et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen
M Jonsson et al.
BIOCHEMICAL JOURNAL (2005)
A proteolytic cascade of kallikreins in the stratum corneum
M Brattsand et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7
C Caubet et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
GM Yousef et al.
PROSTATE (2002)
The plasminogen activation system in tumor growth, invasion, and metastasis
PA Andreasen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2000)
Share Paper
